Carter VanWaes

1.7k total citations
12 papers, 222 citations indexed

About

Carter VanWaes is a scholar working on Oncology, Cancer Research and Immunology. According to data from OpenAlex, Carter VanWaes has authored 12 papers receiving a total of 222 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Cancer Research and 5 papers in Immunology. Recurrent topics in Carter VanWaes's work include interferon and immune responses (4 papers), NF-κB Signaling Pathways (4 papers) and Peptidase Inhibition and Analysis (2 papers). Carter VanWaes is often cited by papers focused on interferon and immune responses (4 papers), NF-κB Signaling Pathways (4 papers) and Peptidase Inhibition and Analysis (2 papers). Carter VanWaes collaborates with scholars based in United States, Türkiye and Israel. Carter VanWaes's co-authors include Özlem Keskin, Ruth Nussinov, Attila Gürsoy, Emine Guven‐Maiorov, Chung‐Jung Tsai, Karel Pacák, James C. Reynolds, Nicholas J. Sarlis, Maria J. Merino and Loukas Gourgiotis and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Carter VanWaes

12 papers receiving 220 citations

Peers

Carter VanWaes
Adrien Lupieri United States
Junyu He China
Deborah Lavin United Kingdom
Sooryeonhwa Jin South Korea
Carter VanWaes
Citations per year, relative to Carter VanWaes Carter VanWaes (= 1×) peers Sharifeh Khosravi

Countries citing papers authored by Carter VanWaes

Since Specialization
Citations

This map shows the geographic impact of Carter VanWaes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carter VanWaes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carter VanWaes more than expected).

Fields of papers citing papers by Carter VanWaes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carter VanWaes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carter VanWaes. The network helps show where Carter VanWaes may publish in the future.

Co-authorship network of co-authors of Carter VanWaes

This figure shows the co-authorship network connecting the top 25 collaborators of Carter VanWaes. A scholar is included among the top collaborators of Carter VanWaes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carter VanWaes. Carter VanWaes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Das, Rita, Jamie Coupar, Anthony D. Saleh, et al.. (2017). Abstract 358: LTB and LTBR mediates alternative Nf-kB activation through NIk and RELB/NF-kB2 to promote cell migration of HNSCC. Cancer Research. 77(13_Supplement). 358–358. 1 indexed citations
2.
Guven‐Maiorov, Emine, Özlem Keskin, Attila Gürsoy, et al.. (2016). TRAF3 signaling: Competitive binding and evolvability of adaptive viral molecular mimicry. Biochimica et Biophysica Acta (BBA) - General Subjects. 1860(11). 2646–2655. 26 indexed citations
3.
Risso, Davide, et al.. (2015). A potential trigger for pine mouth: a case of a homozygous phenylthiocarbamide taster. Nutrition Research. 35(12). 1122–1125. 9 indexed citations
4.
Bian, Yansong, Jiawei Han, Suresh Mohan, et al.. (2015). MEK Inhibitor PD-0325901 Overcomes Resistance to CK2 Inhibitor CX-4945 and Exhibits Anti-Tumor Activity in Head and Neck Cancer. International Journal of Biological Sciences. 11(4). 411–422. 33 indexed citations
5.
Guven‐Maiorov, Emine, Özlem Keskin, Attila Gürsoy, et al.. (2015). The Architecture of the TIR Domain Signalosome in the Toll-like Receptor-4 Signaling Pathway. Scientific Reports. 5(1). 13128–13128. 97 indexed citations
6.
Zhang, Jialing, Hui Chen, Xinping Yang, et al.. (2015). Defective TRAF3 modulates alternative NF-kB signaling and cytokine expression to promote cancer cell survival in HPV positive head and neck cancer (TUM10P.1049). The Journal of Immunology. 194(1_Supplement). 211.30–211.30. 3 indexed citations
10.
Conley, Barbara A., John C. Morris, A. D. Colevas, et al.. (2005). Proteasome inhibitor bortezomib & re-irradiation (rRT) with scheduled treatment break in patients (pts) with head/neck squamous carcinoma (HNSCC). Journal of Clinical Oncology. 23(16_suppl). 5592–5592. 4 indexed citations
11.
Gourgiotis, Loukas, Nicholas J. Sarlis, James C. Reynolds, et al.. (2003). Localization of Medullary Thyroid Carcinoma Metastasis in a Multiple Endocrine Neoplasia Type 2A Patient by 6-[18F]-Fluorodopamine Positron Emission Tomography. The Journal of Clinical Endocrinology & Metabolism. 88(2). 637–641. 42 indexed citations
12.
VanWaes, Carter, et al.. (1997). Inhibition of integrin mediated cell adhesion of human head and neck squamous cell carcinoma to extracellular matrix laminin by monoclonal antibodies. International Journal of Oncology. 11(3). 457–64. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026